Top news of the week: 13.01.2022.
Career And Jobs
Biopharma Executive Perspectives on 2022
BioSpace sat down with 12 executives who shared their thoughts on the coming year and decade.
BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology
DGAP-News: BRAIN Biotech AG / Key word(s): Patent11.01.2022 / 18:50 The issuer is solely responsible for the content of this announcement.Zwingenberg, Germany, January 11th, ...
JPM 2022: Sanofi has designs on creating Big Pharma's 'strongest' immunology franchise, CFO says
Sanofi has been no stranger to the biopharma dealmaking circuit under CEO Paul Hudson, and last year it inked a handful of biotech buyouts for mRNA, an FDA-approved transplant med and more. ...
Amicus gets hit with an 'unexpected' setback on a gene therapy tapped to lead $600M SPAC spinout
Amicus has taken the axe and chopped a gene therapy for Batten disease out of the pipeline after an
Core Summer Internship Program-Summer 2022
We recognize that there are still many uncertainties related to the ongoing COVID-19 pandemic.
First closing of Series A round and onboarding of top biotech leaders to fuel growth in 2022
First closing of Series A round and onboarding of top biotech leaders to fuel growth in 2022 First closing of our Series A round Second closing planned in Q2 ...
JPM 2022: BioNTech builds to a Crescendo with $750M biobucks pact for immunotherapies
After signing yet another deal with COVID-19 vaccine partner Pfizer last week, BioNTech is not stopping anytime soon on the deal front. This time, the vaccine maker is partnering with ...
How family and science moved Exelixis' new CMO to work on oncology blockbusters; While John Maraganore racks up the prizes, his old crew at Alnylam selects president
After 18 years at the FDA and climbing the corporate ladder in biopharma, Vicki Goodman is now in the biotech C-suite for the first time. The new CMO and executive VP of product development ...